The Potential Benefits of Early Use of Biologics for Patients With Systemic JIA

The early use of biologics for people with systemic JIA or Stills disease, that they showed that if you treat them aggressively with biologics first, you can usually get them in remission and even off medications at the end of a year. So maybe there's this window of opportunity that if we treat aggressively early on, we can actually provide a significant lifetime benefit for patients with autoimmune diseases. Yeah. It's going to be really interesting to see how this moves forward.